Chadha MK - Search Results

1

Vitamin D deficiency and insufficiency among patients with prostate cancer.

Trump DL, Chadha MK, Sunga AY, Fakih MG, Ashraf U, Silliman CG, Hollis BW, Nesline MK, Tian L, Tan W, Johnson CS. Trump DL, et al. Among authors: chadha mk. BJU Int. 2009 Oct;104(7):909-14. doi: 10.1111/j.1464-410X.2009.08531.x. Epub 2009 Apr 4. BJU Int. 2009. PMID: 19426195 Free PMC article.

2

Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients.

Chadha MK, Fakih M, Muindi J, Tian L, Mashtare T, Johnson CS, Trump D. Chadha MK, et al. Prostate. 2011 Mar 1;71(4):368-72. doi: 10.1002/pros.21250. Epub 2010 Sep 1. Prostate. 2011. PMID: 20812224 Free PMC article.

3

Phase 2 trial of weekly intravenous 1,25 dihydroxy cholecalciferol (calcitriol) in combination with dexamethasone for castration-resistant prostate cancer.

Chadha MK, Tian L, Mashtare T, Payne V, Silliman C, Levine E, Wong M, Johnson C, Trump DL. Chadha MK, et al. Cancer. 2010 May 1;116(9):2132-9. doi: 10.1002/cncr.24973. Cancer. 2010. PMID: 20166215 Free article. Clinical Trial.

4

Phase II study of fulvestrant (Faslodex) in castration resistant prostate cancer.

Chadha MK, Ashraf U, Lawrence D, Tian L, Levine E, Silliman C, Escott P, Payne V, Trump DL. Chadha MK, et al. Prostate. 2008 Sep 15;68(13):1461-6. doi: 10.1002/pros.20813. Prostate. 2008. PMID: 18618738 Clinical Trial.

5

A dramatic, objective antiandrogen withdrawal response: case report and review of the literature.

Lau YK, Chadha MK, Litwin A, Trump DL. Lau YK, et al. Among authors: chadha mk. J Hematol Oncol. 2008 Nov 5;1:21. doi: 10.1186/1756-8722-1-21. J Hematol Oncol. 2008. PMID: 18986533 Free PMC article.

6

Concurrent oxaliplatin, 5-fluorouracil, and radiotherapy in the treatment of locally advanced esophageal carcinoma.

O'Connor BM, Chadha MK, Pande A, Lombardo JC, Nwogu CE, Nava HR, Yang G, Javle MM. O'Connor BM, et al. Among authors: chadha mk. Cancer J. 2007 Mar-Apr;13(2):119-24. doi: 10.1097/PPO.0b013e318046ee1a. Cancer J. 2007. PMID: 17476140

7

Surgical resection after TNFerade therapy for locally advanced pancreatic cancer.

Chadha MK, Litwin A, Levea C, Iyer R, Yang G, Javle M, Gibbs JF. Chadha MK, et al. JOP. 2009 Sep 4;10(5):535-8. JOP. 2009. PMID: 19734632

8

High-dose octreotide acetate for management of gastroenteropancreatic neuroendocrine tumors.

Chadha MK, Lombardo J, Mashtare T, Wilding GE, Litwin A, Raczyk C, Gibbs JF, Kuvshinoff B, Javle MM, Iyer RV. Chadha MK, et al. Anticancer Res. 2009 Oct;29(10):4127-30. Anticancer Res. 2009. PMID: 19846960 Free article.

9

Phase I Study of Enavatuzumab, a First-in-Class Humanized Monoclonal Antibody Targeting the TWEAK Receptor, in Patients with Advanced Solid Tumors.

Lam ET, Eckhardt SG, Messersmith W, Jimeno A, O'Bryant CL, Ramanathan RK, Weiss GJ, Chadha M, Oey A, Ding HT, Culp PA, Keller SF, Zhao VY, Tsao LC, Singhal A, Holen KD, Von Hoff D. Lam ET, et al. Mol Cancer Ther. 2018 Jan;17(1):215-221. doi: 10.1158/1535-7163.MCT-17-0330. Epub 2017 Oct 20. Mol Cancer Ther. 2018. PMID: 29054986 Free PMC article. Clinical Trial.

10

Anaplastic pancreatic carcinoma. A case report and review of literature.

Chadha MK, LeVea C, Javle M, Kuvshinoff B, Vijaykumar R, Iyer R. Chadha MK, et al. JOP. 2004 Nov 10;5(6):512-5. JOP. 2004. PMID: 15536293 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters